Open Medicine (Nov 2023)
Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
Abstract
No abstracts available.
Open Medicine (Nov 2023)